Skip to content
McGuireWoods
  • Who We Are
  • What We Do
  • Insights
    • Legal Alerts
    • News
    • Events
    • Podcasts
    • Blogs
  • Careers
  • Who We Are
  • What We Do
  • Insights
    • Legal Alerts
    • News
    • Events
    • Podcasts
    • Blogs
  • Careers
Back to News
News Banner 2600x660 1

Victor Moldovan Interviewed on Commercial Real Estate Radio Show

August 5, 2011 | 1-minute read
Save current page as PDF

Partner Victor Moldovan was a guest on the Commercial Real Estate Show’s July 30 radio broadcast on “Health Care Industry and Medical Real Estate.” The national talk show airs weekly on Biz 1190 WAFS AM in Atlanta.

  • Healthcare
  • Atlanta

Related Insights

Legal Alert

North Carolina Eliminates Board Pre-Approval for Dental Management Arrangements: What DSOs and Investors Need to Know

July 10, 2026
5-minute read
Key Takeaways As of July 7, 2026, North Carolina eliminated the requirement that dental management arrangements between dental service organizations...
Press Release

McGuireWoods Advises Texan Allergy in Adair Allergy Acquisition

July 9, 2026
1-minute read
McGuireWoods advised Texan Allergy, LLC, a healthcare and allergy management services company, in its acquisition of Adair Allergy, a clinic...
Press Release

McGuireWoods Lawyers Named to The 2026 Lawdragon 500 Leading Global Tax Lawyers

July 8, 2026
2-minute read
Eleven McGuireWoods lawyers were selected for inclusion in the 2026 “Lawdragon 500 Leading Global Tax Lawyers” guide honoring the nation’s...
Legal Alert

Molecular Testing Expansion in Pathology: Where Strategy, Validation and Oversight Intersect

July 7, 2026
6-minute read
Key Takeaways Many pathology groups have a common misunderstanding when expanding into molecular testing: underestimating the operational burden of later...
Legal Alert

A Pathway for Clinical AI Developers Opens: FDA Clears First Software as a Medical Device With Patient-Facing LLM

July 6, 2026
5-minute read
Key Takeaways On June 25, 2026, UpDoc Inc., a clinical AI company, announced that it received clearance from FDA for...
McGuireWoods logo
  • About Us
  • Locations
  • Alumni
  • Subscribe to Alerts
  • Contact Us
  • Legal Notices
  • Fraud Alert
  • Logo Usage
  • McGuireWoods Consulting

© 2026 McGuireWoods. All rights reserved.

  • Privacy Statement
  • |
  • Cookies Policy
Email Disclaimer

Please note that unsolicited emails and attached information sent to McGuireWoods or a firm attorney via this website do not create an attorney-client relationship. If you are not a McGuireWoods client, do not send us any confidential information. We may not respond to unsolicited emails and do not consider them or attached information confidential. That means we may disclose unsolicited emails and attachments to third parties, and your unsolicited communications will not prevent any lawyer in our firm from representing a party and using the unsolicited communications against you. By clicking “accept” you confirm that you have read and understand this notice.

Accept